These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 24449717

  • 1. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN, Cha YM, Lin G, Asirvatham SJ, Powell BD.
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [Abstract] [Full Text] [Related]

  • 3. Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.
    Varadarajan P, Pai RG.
    J Heart Valve Dis; 2010 Jul; 19(4):412-9. PubMed ID: 20845886
    [Abstract] [Full Text] [Related]

  • 4. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation.
    Eleid MF, Blauwet LA, Cha YM, Connolly HM, Brady PA, Dearani JA, Espinosa RE.
    J Am Coll Cardiol; 2012 Feb 28; 59(9):813-8. PubMed ID: 22361401
    [Abstract] [Full Text] [Related]

  • 5. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R, Krishnaswamy A, Rajeswaran J, Bhargava M, Wazni O, Wilkoff B, Tuzcu EM, Martin D, Thomas J, Blackstone E, Kapadia S.
    Pacing Clin Electrophysiol; 2015 Feb 28; 38(2):259-66. PubMed ID: 25377489
    [Abstract] [Full Text] [Related]

  • 6. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P, Özer N, Ateş AH, Yorgun H, Oto A, Aytemir K.
    Cardiol J; 2015 Feb 28; 22(6):637-44. PubMed ID: 26412607
    [Abstract] [Full Text] [Related]

  • 7. Impact of tricuspid regurgitation after redo valvular surgery on survival in patients with previous mitral valve replacement.
    Fukunaga N, Okada Y, Konishi Y, Murashita T, Kanemitsu H, Koyama T.
    J Thorac Cardiovasc Surg; 2014 Nov 28; 148(5):1983-8. PubMed ID: 24507986
    [Abstract] [Full Text] [Related]

  • 8. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT.
    Pacing Clin Electrophysiol; 2015 Nov 28; 38(11):1267-74. PubMed ID: 26234305
    [Abstract] [Full Text] [Related]

  • 9. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL.
    J Am Coll Cardiol; 2005 May 17; 45(10):1672-5. PubMed ID: 15893186
    [Abstract] [Full Text] [Related]

  • 10. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery.
    Ro SK, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW.
    J Thorac Cardiovasc Surg; 2013 Nov 17; 146(5):1092-7. PubMed ID: 22944085
    [Abstract] [Full Text] [Related]

  • 11. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S, Doyle M, Krishnan K, Biederman RWW.
    Heart Rhythm; 2023 Nov 17; 20(11):1491-1501. PubMed ID: 37506990
    [Abstract] [Full Text] [Related]

  • 12. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW, Pislaru SV, Lin G, Powell BD, Espinosa R, Koestler C, Thome T, Polk L, Li Z, Asirvatham SJ, Cha YM.
    Heart Rhythm; 2018 Jul 17; 15(7):1009-1016. PubMed ID: 29496605
    [Abstract] [Full Text] [Related]

  • 13. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, Weinert L, Maffessanti F, Jeevanandam V, Mor-Avi V, Lang RM.
    JACC Cardiovasc Imaging; 2014 Apr 17; 7(4):337-47. PubMed ID: 24631508
    [Abstract] [Full Text] [Related]

  • 14. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z, Hammami S, Hammami MB, Hammami S, Shuraih M.
    J Electrocardiol; 2015 Apr 17; 48(5):791-7. PubMed ID: 26216371
    [Abstract] [Full Text] [Related]

  • 15. Mid-term results of tricuspid annuloplasty using the MC3 ring for secondary tricuspid valve regurgitation.
    Yoda M, Tanabe H, Kadoma Y, Suma H.
    Interact Cardiovasc Thorac Surg; 2011 Jul 17; 13(1):7-10. PubMed ID: 21454311
    [Abstract] [Full Text] [Related]

  • 16. [Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation].
    Ren CL, Wang Y, Wang R, Li BJ, Geng RY, Gao CQ.
    Zhonghua Yi Xue Za Zhi; 2012 Aug 14; 92(30):2118-22. PubMed ID: 23158275
    [Abstract] [Full Text] [Related]

  • 17. Long-term hemodynamic performance of ATS valves in the aortic position: impact on the progression of late tricuspid regurgitation.
    Jeong DS, Kim WS, Sung K, Yang JH, Jun TG, Lee YT, Park PW.
    J Heart Valve Dis; 2013 Nov 14; 22(6):794-803. PubMed ID: 24597400
    [Abstract] [Full Text] [Related]

  • 18. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
    Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I.
    J Am Coll Cardiol; 2012 Jun 05; 59(23):2075-9. PubMed ID: 22651863
    [Abstract] [Full Text] [Related]

  • 19. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
    Cheng Y, Gao H, Tang L, Li J, Yao L.
    Echocardiography; 2016 Nov 05; 33(11):1689-1696. PubMed ID: 27539645
    [Abstract] [Full Text] [Related]

  • 20. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, Farrar DJ, Milano CA.
    J Thorac Cardiovasc Surg; 2014 Feb 05; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.